- Home
- MDIA vs CELU Comparison
MDIA vs CELU Comparison
Compare MDIA & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDIA
- CELU
- Stock Information
- Founded
- MDIA 2019
- CELU 2016
- Country
- MDIA United States
- CELU United States
- Employees
- MDIA N/A
- CELU N/A
- Industry
- MDIA Broadcasting
- CELU Biotechnology: Pharmaceutical Preparations
- Sector
- MDIA Consumer Discretionary
- CELU Health Care
- Exchange
- MDIA Nasdaq
- CELU Nasdaq
- Market Cap
- MDIA 72.4M
- CELU 64.3M
- IPO Year
- MDIA N/A
- CELU N/A
- Fundamental
- Price
- MDIA $1.42
- CELU $2.32
- Analyst Decision
- MDIA
- CELU Strong Buy
- Analyst Count
- MDIA 0
- CELU 1
- Target Price
- MDIA N/A
- CELU $6.00
- AVG Volume (30 Days)
- MDIA 27.0K
- CELU 133.2K
- Earning Date
- MDIA 11-13-2025
- CELU 08-29-2025
- Dividend Yield
- MDIA N/A
- CELU N/A
- EPS Growth
- MDIA N/A
- CELU N/A
- EPS
- MDIA 0.40
- CELU N/A
- Revenue
- MDIA $121,938,000.00
- CELU $44,590,000.00
- Revenue This Year
- MDIA N/A
- CELU $23.29
- Revenue Next Year
- MDIA N/A
- CELU N/A
- P/E Ratio
- MDIA $3.51
- CELU N/A
- Revenue Growth
- MDIA 165.75
- CELU 4.45
- 52 Week Low
- MDIA $0.79
- CELU $1.00
- 52 Week High
- MDIA $2.71
- CELU $5.22
- Technical
- Relative Strength Index (RSI)
- MDIA 58.29
- CELU 37.21
- Support Level
- MDIA $1.37
- CELU $2.02
- Resistance Level
- MDIA $1.50
- CELU $2.53
- Average True Range (ATR)
- MDIA 0.08
- CELU 0.30
- MACD
- MDIA 0.01
- CELU -0.14
- Stochastic Oscillator
- MDIA 66.67
- CELU 15.08
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.